LACHESIS BIOSCIENCES
Who is LACHESIS BIOSCIENCES?
Lachesis BioSciences is a clinical-stage biotechnology company targeting dementia caused by Alzheimer’s and Parkinson’s disease. Lachesis Biosciences is developing LBIO-R32, a rivastigmine nasal spray for the treatment of mild to severe Alzheimer's disease dementia and mild to moderate Parkinson’s ...See more
Industry & Specialities
Others
Countries of Operation
Australia
Headquarters:
Australia
Company Type:
SME
Company size:
11-50 Employees
Address:
664 COLLINS ST; LEVEL 13; DOCKLANDS, VICTORIA 3008, AU
Employees by Department
- The Rest (1)
- Total (1)
Key Decision Makers
Simone Scovell
Non Executive Director
Employees by Seniority
C-level
0employees
Senior
0employees
Non-managers
0employees
Financials
LOW
spending power
Funding Status
Private
Associated Legal Entities
0 entities
Discover More Companies
Lookalike companies
Featured Lists
- SMEs in Singapore
- MNCs / Large Enterprises in Singapore
Frequently Asked Questions (FAQ)
- What is the funding status of LACHESIS BIOSCIENCES?
- Where is LACHESIS BIOSCIENCES's headquarter?
- What LACHESIS BIOSCIENCES's spending power?
- Does LACHESIS BIOSCIENCES have a presence in the domain it operates in?